0000950170-23-073331.txt : 20231227
0000950170-23-073331.hdr.sgml : 20231227
20231227164743
ACCESSION NUMBER: 0000950170-23-073331
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231222
FILED AS OF DATE: 20231227
DATE AS OF CHANGE: 20231227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Falcon Fund 2 Holding Company, L.P.
CENTRAL INDEX KEY: 0001817718
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35887
FILM NUMBER: 231518478
BUSINESS ADDRESS:
STREET 1: 21 WATERWAY AVENUE
STREET 2: SUITE 225
CITY: THE WOODLANDS
STATE: TX
ZIP: 77380
BUSINESS PHONE: 2813641555
MAIL ADDRESS:
STREET 1: 21 WATERWAY AVENUE
STREET 2: SUITE 225
CITY: THE WOODLANDS
STATE: TX
ZIP: 77380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MIMEDX GROUP, INC.
CENTRAL INDEX KEY: 0001376339
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 262792552
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1775 W OAK COMMONS COURT, NE
CITY: MARIETTA
STATE: GA
ZIP: 30062
BUSINESS PHONE: (770) 651-9100
MAIL ADDRESS:
STREET 1: 1775 W OAK COMMONS COURT, NE
CITY: MARIETTA
STATE: GA
ZIP: 30062
FORMER COMPANY:
FORMER CONFORMED NAME: Alynx, Co.
DATE OF NAME CHANGE: 20060922
4
1
ownership.xml
4
X0508
4
2023-12-22
0001376339
MIMEDX GROUP, INC.
MDXG
0001817718
Falcon Fund 2 Holding Company, L.P.
21 WATERWAY AVENUE, SUITE 225
THE WOODLANDS
TX
77380
false
false
true
false
false
Common Stock, par value $0.001 per share
2023-12-22
4
C
false
28195249
A
28195249
D
Series B Preferred Stock, par value $0.001 per share
3.85
2023-12-22
4
C
false
90000
D
Common Stock
28195249
0
D
On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.
Falcon Fund 2 Holding Company, L.P., a Delaware limited partnership; By: EW Healthcare Partners Fund 2-UGP, LLC, its general partner; By: Martin P. Sutter, Authorized Signatory /s/ Martin P. Sutter
2023-12-27